Home / Companies / ALX Oncology Holdings Inc. / 11 Jun 2025
ALX Oncology Holdings Inc.: meeting of 11 Jun 2025
Votes reported on Form N-PX, item by item
128 Form N-PX filers reported votes at the ALX Oncology Holdings Inc. meeting of 11 Jun 2025. Their records fall into 3 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 60.8% of reported votes for; 33 filers withheld from or voted against at least one nominee.
166 vote records from 49 filers. 1 of the 49 filers that marked the item either way voted against management.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
178 vote records from 128 filers. 74 of the 124 filers that marked the item either way voted against management. 4 filers reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
83 vote records from 49 filers. 1 of the 49 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Say-on-pay | 3. Auditor |
|---|---|---|---|
| Vanguard | For | For | For |
| BlackRock and iShares | For | Against * | For |
| Fidelity | Split or no vote | Against * | For |
| Dimensional | No report | Against * | No report |
| State Street and SPDR | For | For | For |
| American Century | No report | Against * | No report |
| Invesco | No report | Against * | No report |
| Equitable | Split or no vote | Against * | For |
| Charles Schwab | Split or no vote | For | For |
| Nuveen and TIAA | For | Against * | For |
| ProShares and ProFunds | Split or no vote | Against * | For |
| John Hancock and Manulife | No report | Against * | No report |
| Morgan Stanley, Eaton Vance and Calvert | Split or no vote | Against * | For |
| J.P. Morgan | No report | For | No report |
| Goldman Sachs | Split or no vote | Against * | For |
| PGIM and Prudential | No report | For | No report |
| Northern Trust and FlexShares | Split or no vote | For | For |
| SEI | Split or no vote | For | For |
| T. Rowe Price | Split or no vote | Against * | For |
| Lincoln Financial | For | For | For |
| First Trust | No report | Split or no vote | No report |
| Nationwide | Split or no vote | Against * | For |
| Guggenheim and Rydex | Split or no vote | Against * | For |
| Columbia Threadneedle | For | Against * | For |
| BNY Mellon | No report | Against * | No report |
| Principal | No report | Against * | No report |
| Pacific Life funds | Split or no vote | Against * | For |
| Global X | Split or no vote | For | For |
| Federated Hermes | No report | For | No report |
| AllianceBernstein | No report | Against * | No report |
| DWS | Split or no vote | Against * | For |
| Neuberger Berman | No report | For | No report |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the ALX Oncology Holdings Inc. meeting?
128 Form N-PX filers reported votes at the meeting of 11 Jun 2025. On say-on-pay, 74 of 124 voted against management (59.7%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by ALX Oncology Holdings Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for ALX Oncology Holdings Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing ALX Oncology Holdings Inc. with a meeting date within three days of 11 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.